Related references
Note: Only part of the references are listed.Design and synthesis of 1,2,3-triazole-etodolac hybrids as potent anticancer molecules
Bhaskar Kummari et al.
RSC ADVANCES (2017)
Recent advances bioactive 1,2,4-triazole-3-thiones
S. Guniz Kucukguzel et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Anti-cancer and anti-hepatitis C virus NS5B polymerase activity of etodolac 1,2,4-triazoles
Pelin Cikla-Suzgun et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2015)
Synthesis, Cytotoxicity, and Pro-Apoptosis Activity of Etodolac Hydrazide Derivatives as Anticancer Agents
Pelin Cikla et al.
ARCHIV DER PHARMAZIE (2013)
Synthesis and antimicrobial evaluation of some novel 1,2,4-triazole and 1,3,4-thiadiazole derivatives
Lukasz Popiolek et al.
MEDICINAL CHEMISTRY RESEARCH (2013)
Etodolac Thiosemicarbazides: A novel class of hepatitis C virus NS5B polymerase inhibitors
Pelin Cikla et al.
MARMARA PHARMACEUTICAL JOURNAL (2013)
The Development of MetAP-2 Inhibitors in Cancer Treatment
S. -Q. Yin et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Synthesis and antitumor activity of 1,2,4-triazoles having 1,4-benzodioxan fragment as a novel class of potent methionine aminopeptidase type II inhibitors
Ya-Ping Hou et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Highly potent inhibitors of methionine aminopeptidase-2 based on a 1,2,4-triazole pharmacophore
Joseph P. Marino et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Etodolac inhibits EBER expression and induces Bcl-2-regulated apoptosis in Burkitt's lymphoma cells
M Kobayashi et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2005)
Proteomics-based target identification - Bengamides as a new class of methionine aminopeptidase inhibitors
H Towbin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Some 3-thioxo/alkylthio-1,2,4-triazoles with a substituted thiourea moiety as possible antimycobacterials
I Küçükgüzel et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Share Paper
